The groundbreaking treatment of tirzepatide peptide represents a major advance in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide318372.ziblogs.com/42378306/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment